Diseases, Conditions, Syndromes

FDA approves Eohilia for eosinophilic esophagitis

The U.S. Food and Drug Administration has approved Takeda's Eohilia (budesonide oral suspension) as the first and only oral treatment for eosinophilic esophagitis (EoE).

Medications

Weekly dupilumab beneficial in eosinophilic esophagitis

Subcutaneous dupilumab administered weekly is associated with improved histologic outcomes and alleviation of symptoms among patients with eosinophilic esophagitis, according to a study published in the Dec. 22 issue of the ...

Pediatrics

A new way to improve outcomes in kids with eosinophilic esophagitis

A new study from Ann & Robert H. Lurie Children's Hospital of Chicago determined the threshold for a new measure of early scarring in the esophagus of children with eosinophilic esophagitis (EoE), which allows immediate intervention ...

page 2 from 5